Canadian Hematology Today.
3 issues per year (March, June, October)
How to Submit
Manuscripts for Canadian Hematology Today should be submitted digitally to email@example.com. Canadian Hematology Today welcomes submissions from members of the Canadian medical community and does not charge article processing fees or any other fees for manuscript submission or publication.
Manuscripts should be submitted in .doc or .docx (Microsoft Word) formats only. When preparing your manuscript, please insert all graphics (figures, tables, etc.) into the main text after the paragraph where each is first cited.
Canadian Hematology Today does not set limits on the length of manuscripts, but suggests that submissions be no longer than 2,000 words, exclusive of figures and references. Short abstracts (under 250 words) may be optionally included but are not required for all articles.
Standard-length articles should include no more than 2–3 figures, tables, and other graphics. References should be formatted using Vancouver style (also known as the citation–sequence or author–number system). They should be listed as end references in the order they appear and identified in text using superscript Arabic numerals.
Canadian Hematology Today publishes exclusively original content that has not previously been published, and condemns all forms of plagiarism, including self-plagiarism. Plagiarism is the use of others' ideas or words without attribution, presenting them as original rather than derived from an existing source. Self-plagiarism involves using one's own previously published writing without citing it formally, and must be avoided or clarified.
All articles published in Canadian Hematology Today are subject to peer review by the Editorial Board and will be assessed for scientific content and quality. Submitted manuscripts will also be evaluated for alignment with the journal's aims and scope and adherence to its ethical policies.
The submitting author, who is generally the corresponding author, is responsible for the manuscript during the submission and peer-review process and must ensure that queries, revisions, and approvals can be provided within a 72-hour time period during the review of their manuscript.
Upon review, a submitted manuscript may be rejected, accepted with corrections or a request for changes (in which case the Editorial Board may request the manuscript be returned for a second review), or accepted with minor edits. In all cases, the editorial team will forward reviewers' comments, suggestions, or requests to the submitting author. In the event that an article is rejected, the editorial team will inform the submitting author of the reasons for this decision.
All accepted manuscripts undergo copyediting to conform to the journal's stylistic and editorial standards. Corrections and suggested linguistic changes are sent to the submitting author for approval prior to publication.
Canadian Hematology Today publishes all of its articles in both English and French. Finalized English-language articles will be translated into French, and upon approval by the submitting author will be published in the French-language version of Canadian Hematology Today.